Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$913M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 3 |
Microsoft
MSFT
|
+$369M |
| 4 |
MongoDB
MDB
|
+$345M |
| 5 |
Grab
GRAB
|
+$339M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$867M |
| 2 |
PayPal
PYPL
|
+$519M |
| 3 |
Alibaba
BABA
|
+$393M |
| 4 |
CrowdStrike
CRWD
|
+$360M |
| 5 |
DOCU
DocuSign
DOCU
|
+$335M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.56% |
| 2 | Healthcare | 12.66% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
Assembly Biosciences
ASMB
$530M
| $104K | ﹤0.01% |
3,723
-397
| -10% | -$13K |
|
3802
Alaunos Therapeutics
TCRT
$4.84M
| $104K | ﹤0.01% |
633
-51
| -7% | -$11.2K |
|
3803
Lineage Cell Therapeutics
LCTX
$286M
| $103K | ﹤0.01% |
42,283
-13,360
| -24% | -$31.3K |
|
|
ASXC
3804
DELISTED
Asensus Surgical, Inc.
ASXC
| $103K | ﹤0.01% |
92,788
-19,285
| -17% | -$29.8K |
|
3805
Cogent Biosciences
COGT
$7.1B
| $102K | ﹤0.01% |
11,799
-336
| -3% | -$2.92K |
|
|
KMF
3806
DELISTED
Kayne Anderson NextGen Energy & Infrastructure, Inc.
KMF
| $101K | ﹤0.01% |
14,088
-21,687
| -61% | -$161K |
|
|
BORR
3807
Borr Drilling
BORR
$1.28B
| $100K | ﹤0.01% |
+48,307
| New | +$102K |
|
3808
Culp Inc
CULP
$42.7M
| $100K | ﹤0.01% |
10,526
-678
| -6% | -$7.81K |
|
|
LITS
3809
Lite Strategy Inc
LITS
$29.6M
| $100K | ﹤0.01% |
1,871
-54
| -3% | -$3.01K |
|
|
NCTY
3810
The9 Ltd
NCTY
$69.2M
| $100K | ﹤0.01% |
+1,488
| New | +$151K |
|
3811
Arbutus Biopharma
ABUS
$907M
| $99K | ﹤0.01% |
25,385
-3,795
| -13% | -$14.7K |
|
3812
CytomX Therapeutics
CTMX
$750M
| $99K | ﹤0.01% |
22,899
-7,276
| -24% | -$42.6K |
|
|
THRN
3813
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $96K | ﹤0.01% |
+15,380
| New | +$120K |
|
3814
Clover Health Investments
CLOV
$2.43B
| $95K | ﹤0.01% |
25,629
+15,019
| +142% | +$92.1K |
|
3815
NextCure
NXTC
$31.3M
| $95K | ﹤0.01% |
1,313
-140
| -10% | -$11.7K |
|
3816
MiNK Therapeutics
INKT
$54.6M
| $94K | ﹤0.01% |
+2,107
| New | +$251K |
|
|
ZVO
3817
DELISTED
Zovio Inc. Common Stock
ZVO
| $94K | ﹤0.01% |
74,013
-4,794
| -6% | -$8.41K |
|
3818
Lucid Diagnostics
LUCD
$183M
| $93K | ﹤0.01% |
+17,331
| New | +$141K |
|
3819
Shattuck Labs
STTK
$682M
| $93K | ﹤0.01% |
10,904
-791
| -7% | -$10.9K |
|
3820
Cartesian Therapeutics
RNAC
$265M
| $92K | ﹤0.01% |
940
-172
| -15% | -$18.5K |
|
|
LUNA
3821
DELISTED
Luna Innovations Incorporated
LUNA
| $90K | ﹤0.01% |
10,649
-3,877
| -27% | -$34.8K |
|
3822
Lyell Immunopharma
LYEL
$351M
| $89K | ﹤0.01% |
+577
| New | +$129K |
|
|
RENT
3823
Rent the Runway
RENT
$122M
| $89K | ﹤0.01% |
+545
| New | +$145K |
|
3824
Rekor Systems
REKR
$91.2M
| $87K | ﹤0.01% |
13,230
-7,983
| -38% | -$75.1K |
|
3825
Denison Mines
DNN
$2.95B
| $86K | ﹤0.01% |
62,943
| – | – |
|
Similar funds
Invesco's Q4 2021 Portfolio in Review
As of Q4 2021, Invesco held 4,196 positions worth $415B, up 5.1% from $395B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Invesco's Q4 2021 filing shows 190 new, 1,645 increased, 2,044 reduced and 170 closed positions. Its largest new stake was Grab: 44,484,753 shares worth $317M. The largest sale was Meta Platforms (Facebook), an estimated $867M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q4 2021 buy was Grab: 44,484,753 shares worth $317M.
- Invesco added most to Apple in Q4 2021, an estimated $913M increase.
- Invesco's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $867M.
- Invesco fully exited Kansas City Southern in Q4 2021, selling an estimated $110M.
- Invesco's ten largest holdings make up 12% of its $415B portfolio in Q4 2021.
- Invesco opened 190 new positions and closed 170 in Q4 2021.
- Invesco's portfolio value rose 5.1% quarter-over-quarter to $415B.
Based on Invesco's 13F filing for Q4 2021, filed 14 Feb 2022.